S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94

Compare Stocks

Date Range: 

 Bio-Rad LaboratoriesWatersAvantorPerkinElmer
SymbolNYSE:BIONYSE:WATNYSE:AVTRNYSE:PKI
Price Information
Current Price$721.48$344.71$38.35$169.82
50-Day Moving Average$773.89$390.16$40.41$180.85
52-Week Low$507.22$208.81$22.49$119.95
52-Week High$832.70$428.22$44.37$192.00
MarketRank™
Overall Score2.31.72.52.4
Analysis Score1.51.13.51.4
Community Score4.43.95.04.4
Dividend Score0.00.00.01.7
Ownership Score4.22.52.52.5
Earnings & Valuation Score1.31.31.31.9
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuy
Consensus Price Target$770.00$301.67$43.69$152.77
% Upside from Price Target6.73% upside-12.49% downside13.92% upside-10.04% downside
Trade Information
Market Cap$21.48 billion$21.15 billion$22.40 billion$19.04 billion
Beta0.850.81.681.1
Average Volume156,088374,9944,080,596851,565
Sales & Book Value
Annual Revenue$2.55 billion$2.37 billion$6.39 billion$3.78 billion
Price / Sales8.448.943.505.03
Cashflow$9.35 per share$9.13 per share$1.77 per share$9.60 per share
Price / Cash77.1537.7621.7117.69
Book Value$331.05 per share$3.74 per share$2.88 per share$33.36 per share
Price / Book2.1892.1713.325.09
Profitability
Net Income$3.81 billion$521.57 million$116.60 million$727.89 million
EPS$10.52$9.05$0.89$8.30
Trailing P/E Ratio5.3832.5885.2216.16
Forward P/E Ratio58.4229.6125.4028.02
P/E GrowthN/A4.201.150.50
Net Margins140.48%24.73%4.47%24.35%
Return on Equity (ROE)4.65%387.10%44.55%37.29%
Return on Assets (ROA)3.52%22.56%7.64%17.54%
Dividend
Annual PayoutN/AN/AN/A$0.28
Dividend YieldN/AN/AN/A0.16%
Three-Year Dividend GrowthN/AN/AN/AN/A
Payout RatioN/AN/AN/A3.37%
Years of Consecutive Dividend GrowthN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A5.98%2.83%0.55%
Current Ratio3.90%2.41%1.76%2.01%
Quick Ratio2.88%1.89%1.15%1.56%
Ownership Information
Institutional Ownership Percentage63.14%88.08%90.20%92.84%
Insider Ownership Percentage27.67%1.10%2.00%0.55%
Miscellaneous
Employees8,0007,40012,40014,000
Shares Outstanding29.77 million61.36 million584.16 million112.11 million
Next Earnings Date10/28/2021 (Confirmed)10/26/2021 (Estimated)10/28/2021 (Confirmed)11/2/2021 (Confirmed)
OptionableOptionableOptionableNot OptionableOptionable
SourceHeadline
Two Former PerkinElmer Lab Workers Allege Testing Improprieties - MyNewsLA.comTwo Former PerkinElmer Lab Workers Allege Testing Improprieties - MyNewsLA.com
mynewsla.com - October 15 at 7:22 PM
Two Former PerkinElmer Lab Workers Allege Testing Improprieties - KFI AM 640Two Former PerkinElmer Lab Workers Allege Testing Improprieties - KFI AM 640
kfiam640.iheart.com - October 15 at 1:52 PM
PerkinElmer (PKI) Receives EUA from FDA for Latest Assay - NasdaqPerkinElmer (PKI) Receives EUA from FDA for Latest Assay - Nasdaq
nasdaq.com - October 15 at 1:52 PM
PerkinElmer (PKI) Receives EUA from FDA for Latest AssayPerkinElmer (PKI) Receives EUA from FDA for Latest Assay
finance.yahoo.com - October 15 at 1:52 PM
PerkinElmer - Consensus Indicates Potential 7.6% Upside - DirectorsTalk InterviewsPerkinElmer - Consensus Indicates Potential 7.6% Upside - DirectorsTalk Interviews
directorstalkinterviews.com - October 15 at 8:52 AM
PerkinElmer : Collaborates With Leading Life Science Incubators LabCentral and MBC BioLabs to Help Further Drug Discovery - marketscreener.comPerkinElmer : Collaborates With Leading Life Science Incubators LabCentral and MBC BioLabs to Help Further Drug Discovery - marketscreener.com
marketscreener.com - October 14 at 5:49 PM
Global Single-mode Microplate Readers Market 2021 Industry Scenario and Demand – Tecan Group (Switzerland), PerkinElmer (US), Danaher (Beckman Coulter And Molecular Devices) (US) – Radford University Athletics - Radford University AthleticsGlobal Single-mode Microplate Readers Market 2021 Industry Scenario and Demand – Tecan Group (Switzerland), PerkinElmer (US), Danaher (Beckman Coulter And Molecular Devices) (US) – Radford University Athletics - Radford University Athletics
ruhighlanders.com - October 14 at 12:49 PM
Wilk Calls For Release Of Lab Report From Valencia Based Covid Lab - SCVNEWS.comWilk Calls For Release Of Lab Report From Valencia Based Covid Lab - SCVNEWS.com
scvnews.com - October 13 at 6:10 PM
PerkinElmers (PKI) Arm Gets FDA EUA Nod for Latest Assay - NasdaqPerkinElmer's (PKI) Arm Gets FDA EUA Nod for Latest Assay - Nasdaq
nasdaq.com - October 13 at 1:09 PM
PerkinElmers (PKI) Arm Gets FDA EUA Nod for Latest AssayPerkinElmer's (PKI) Arm Gets FDA EUA Nod for Latest Assay
finance.yahoo.com - October 13 at 1:09 PM
Dairy Dialog podcast 154: Danone North America, Pathways to Dairy Net Zero, PerkinElmer - DairyReporter.comDairy Dialog podcast 154: Danone North America, Pathways to Dairy Net Zero, PerkinElmer - DairyReporter.com
dairyreporter.com - October 13 at 3:09 AM
On a detour from trip to D.C., India’s finance minister meets with Boston execs - BetaBostonOn a detour from trip to D.C., India’s finance minister meets with Boston execs - BetaBoston
bostonglobe.com - October 12 at 9:59 PM
Wilk calls for release of Valencia COVID-19 lab report - Santa Clarita Valley SignalWilk calls for release of Valencia COVID-19 lab report - Santa Clarita Valley Signal
signalscv.com - October 12 at 9:59 PM
Heres Why You Should Hold on to PerkinElmer (PKI) Stock Now - EntrepreneurHere's Why You Should Hold on to PerkinElmer (PKI) Stock Now - Entrepreneur
entrepreneur.com - October 12 at 4:58 PM
PerkinElmer is Now Oversold (PKI) - NasdaqPerkinElmer is Now Oversold (PKI) - Nasdaq
nasdaq.com - October 12 at 4:58 PM
PerkinElmer Schedules Earnings Call for Tuesday, November 2, 2021PerkinElmer Schedules Earnings Call for Tuesday, November 2, 2021
finance.yahoo.com - October 12 at 4:58 PM
Preeclampsia Diagnostics Market Scrutinized In New Research By 2027| PerkinElmer Inc., Siemens Healthineers AG, DRG INSTRUMENTS GMBH – Otterbein 360 - Otterbein 360Preeclampsia Diagnostics Market Scrutinized In New Research By 2027| PerkinElmer Inc., Siemens Healthineers AG, DRG INSTRUMENTS GMBH – Otterbein 360 - Otterbein 360
otterbein360.com - October 12 at 11:58 AM
Simultaneous Thermal Analysis?STA? Market Size, Growth and Key Companies – PerkinElmer, Instrument Specialists, NETZSCH Group – Technology, Shimadzu Corporation, Agilent Technologies, JOEL, SCINCO – Otterbein 360 - Otterbein 360Simultaneous Thermal Analysis?STA? Market Size, Growth and Key Companies – PerkinElmer, Instrument Specialists, NETZSCH Group – Technology, Shimadzu Corporation, Agilent Technologies, JOEL, SCINCO – Otterbein 360 - Otterbein 360
otterbein360.com - October 12 at 6:58 AM
Global Atomic Absorption Spectroscopy Instrument Market 2021 Industry Scenario – PerkinElmer, Persee, - Global Banking And Finance ReviewGlobal Atomic Absorption Spectroscopy Instrument Market 2021 Industry Scenario – PerkinElmer, Persee, - Global Banking And Finance Review
globalbankingandfinance.com - October 12 at 6:58 AM
ICP-MS Spectrometer Market Size, Growth and Key Companies – PerkinElmer, Spectro, Thermofisher, Agilent Technologies, BRUKER, HITACHI, Analytik jena – Otterbein 360 - Otterbein 360ICP-MS Spectrometer Market Size, Growth and Key Companies – PerkinElmer, Spectro, Thermofisher, Agilent Technologies, BRUKER, HITACHI, Analytik jena – Otterbein 360 - Otterbein 360
otterbein360.com - October 11 at 11:07 PM
Gas Chromatography Detector Market By Key Players (Perkinelmer Inc., Thermo Fisher Scientific Inc., WR Grace and Company, Restek Corporation); Based on 2020 COVID-19 Worldwide Spread – Otterbein 360 - Otterbein 360Gas Chromatography Detector Market By Key Players (Perkinelmer Inc., Thermo Fisher Scientific Inc., WR Grace and Company, Restek Corporation); Based on 2020 COVID-19 Worldwide Spread – Otterbein 360 - Otterbein 360
otterbein360.com - October 11 at 8:06 AM
Chromatography Detectors Market By Key Players (Knauer Gmbh, Perkinelmer Inc., Scientific Repair Inc. (Sri Instruments), Phenomenex Inc.); Based on 2020 COVID-19 Worldwide Spread – Otterbein 360 - Otterbein 360Chromatography Detectors Market By Key Players (Knauer Gmbh, Perkinelmer Inc., Scientific Repair Inc. (Sri Instruments), Phenomenex Inc.); Based on 2020 COVID-19 Worldwide Spread – Otterbein 360 - Otterbein 360
otterbein360.com - October 11 at 8:06 AM
FDA Grants Emergency Use Authorization for Single Test to Differentiate Between COVID-19, Flu, RSV - Pharmacy TimesFDA Grants Emergency Use Authorization for Single Test to Differentiate Between COVID-19, Flu, RSV - Pharmacy Times
pharmacytimes.com - October 8 at 6:56 PM
PerkinElmers Horizon Discovery CHOSOURCE platform expands - Cambridge NetworkPerkinElmer's Horizon Discovery CHOSOURCE platform expands - Cambridge Network
cambridgenetwork.co.uk - October 7 at 12:58 PM
PerkinElmer Reports Received FDA Emergency Use Authorization For Respiratory SARS-CoV-2 Panel - BenzingaPerkinElmer Reports Received FDA Emergency Use Authorization For Respiratory SARS-CoV-2 Panel - Benzinga
benzinga.com - October 7 at 12:58 PM
DateCompanyBrokerageAction
10/14/2021AvantorCowen
Lower Price Target
9/10/2021AvantorStifel Nicolaus
Boost Price Target
9/10/2021AvantorCredit Suisse Group
Boost Price Target
9/9/2021AvantorKeyCorp
Boost Price Target
8/30/2021AvantorRaymond James
Initiated Coverage
8/9/2021PerkinElmerRoyal Bank of Canada
Boost Price Target
8/4/2021WatersSVB Leerink
Boost Price Target
8/4/2021WatersRobert W. Baird
Boost Price Target
8/4/2021WatersCitigroup
Boost Price Target
8/2/2021AvantorTruist Securities
Boost Price Target
8/2/2021AvantorMorgan Stanley
Boost Price Target
8/2/2021AvantorTruist
Boost Price Target
8/2/2021AvantorCitigroup
Boost Price Target
8/2/2021AvantorBarclays
Boost Price Target
8/2/2021AvantorPiper Sandler
Upgrade
7/30/2021Bio-Rad LaboratoriesWells Fargo & Company
Boost Price Target
7/30/2021AvantorCredit Suisse Group
Boost Price Target
7/30/2021AvantorWells Fargo & Company
Boost Price Target
7/30/2021AvantorKeyCorp
Boost Price Target
7/27/2021PerkinElmerEvercore ISI
Reiterated Rating
7/27/2021PerkinElmerRobert W. Baird
Reiterated Rating
7/6/2021WatersEvercore ISI
Upgrade
6/15/2021PerkinElmerWolfe Research
Upgrade
6/4/2021AvantorThe Goldman Sachs Group
Initiated Coverage
5/6/2021WatersSVB Leerink
Boost Price Target
5/6/2021WatersWells Fargo & Company
Boost Price Target
4/29/2021AvantorCredit Suisse Group
Boost Price Target
4/29/2021AvantorRaymond James
Boost Price Target
4/29/2021AvantorMorgan Stanley
Boost Price Target
4/29/2021AvantorJPMorgan Chase & Co.
Boost Price Target
4/29/2021AvantorRobert W. Baird
Boost Price Target
4/29/2021AvantorPiper Sandler
Boost Price Target
4/29/2021AvantorStifel Nicolaus
Upgrade
3/8/2021AvantorBarclays
Initiated Coverage
3/2/2021AvantorBarclays
Initiated Coverage
2/12/2021Bio-Rad LaboratoriesCitigroup
Boost Price Target
2/5/2021Bio-Rad LaboratoriesJefferies Financial Group
Boost Price Target
2/4/2021AvantorCitigroup
Boost Price Target
2/3/2021WatersCitigroup
Boost Price Target
2/3/2021PerkinElmerCitigroup
Boost Price Target
1/7/2021WatersWells Fargo & Company
Downgrade
1/7/2021PerkinElmerWells Fargo & Company
Upgrade
12/17/2020WatersCleveland Research
Upgrade
12/16/2020WatersSmith Barney Citigroup
Upgrade
12/11/2020PerkinElmerSmith Barney Citigroup
Boost Price Target
12/2/2020WatersThe Goldman Sachs Group
Initiated Coverage
12/2/2020PerkinElmerThe Goldman Sachs Group
Initiated Coverage
11/12/2020PerkinElmerThe Goldman Sachs Group
Initiated Coverage
11/9/2020WatersKeyCorp
Initiated Coverage
11/9/2020PerkinElmerKeyCorp
Initiated Coverage
11/9/2020PerkinElmerNeedham & Company LLC
Boost Price Target
10/30/2020Bio-Rad LaboratoriesSmith Barney Citigroup
Boost Price Target
10/30/2020Bio-Rad LaboratoriesWells Fargo & Company
Boost Price Target
10/29/2020PerkinElmerSmith Barney Citigroup
Boost Price Target
10/29/2020PerkinElmerWells Fargo & Company
Boost Price Target
10/29/2020PerkinElmerRobert W. Baird
Boost Price Target
10/28/2020WatersStifel Nicolaus
Boost Price Target
10/28/2020WatersSmith Barney Citigroup
Boost Price Target
10/28/2020WatersWells Fargo & Company
Boost Price Target
10/28/2020WatersSVB Leerink
Boost Price Target
9/11/2020PerkinElmerNeedham & Company LLC
Upgrade
9/3/2020Bio-Rad LaboratoriesJefferies Financial Group
Reiterated Rating
9/3/2020Bio-Rad LaboratoriesWells Fargo & Company
Reiterated Rating
8/10/2020PerkinElmerBMO Capital Markets
Boost Price Target
7/31/2020Bio-Rad LaboratoriesWells Fargo & Company
Boost Price Target
7/31/2020Bio-Rad LaboratoriesCitigroup
Boost Price Target
7/30/2020Bio-Rad LaboratoriesWells Fargo & Company
Reiterated Rating
7/29/2020WatersStifel Nicolaus
Boost Price Target
7/29/2020WatersSVB Leerink
Boost Price Target
7/29/2020WatersCitigroup
Boost Price Target
7/29/2020PerkinElmerJPMorgan Chase & Co.
Boost Price Target
7/29/2020PerkinElmerStifel Nicolaus
Boost Price Target
7/29/2020PerkinElmerWells Fargo & Company
Boost Price Target
7/29/2020PerkinElmerCfra
Upgrade
7/28/2020WatersNeedham & Company LLC
Initiated Coverage
7/28/2020WatersJPMorgan Chase & Co.
Upgrade
7/16/2020WatersWells Fargo & Company
Upgrade
7/13/2020PerkinElmerNeedham & Company LLC
Initiated Coverage
5/21/2020Bio-Rad LaboratoriesWells Fargo & Company
Boost Price Target
5/7/2020Bio-Rad LaboratoriesCitigroup
Boost Price Target
5/7/2020PerkinElmerUBS Group
Boost Price Target
5/6/2020PerkinElmerRobert W. Baird
Boost Price Target
5/6/2020PerkinElmerCfra
Lower Price Target
5/6/2020PerkinElmerJPMorgan Chase & Co.
Boost Price Target
4/29/2020WatersBank of America
Lower Price Target
4/29/2020WatersStifel Nicolaus
Boost Price Target
4/29/2020WatersSVB Leerink
Lower Price Target
4/20/2020Bio-Rad LaboratoriesCitigroup
Boost Price Target
3/30/2020Bio-Rad LaboratoriesWells Fargo & Company
Lower Price Target
3/26/2020Bio-Rad LaboratoriesBarclays
Lower Price Target
3/20/2020Bio-Rad LaboratoriesCitigroup
Lower Price Target
3/3/2020Bio-Rad LaboratoriesCitigroup
Reiterated Rating
2/14/2020Bio-Rad LaboratoriesWells Fargo & Company
Boost Price Target
1/7/2020Bio-Rad LaboratoriesWells Fargo & Company
Initiated Coverage
1/6/2020Bio-Rad LaboratoriesCitigroup
Initiated Coverage
8/20/2019Bio-Rad LaboratoriesThe Goldman Sachs Group
Upgrade
8/2/2019Bio-Rad LaboratoriesBarclays
Boost Price Target
5/9/2019Bio-Rad LaboratoriesDeutsche Bank Aktiengesellschaft
Boost Price Target
5/9/2019Bio-Rad LaboratoriesBarclays
Boost Price Target
3/1/2019Bio-Rad LaboratoriesDeutsche Bank Aktiengesellschaft
Boost Price Target
(Data available from 10/17/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.